Artículos por temáticas

Visual search and target detection during simulated driving in Parkinson's disease.

Ranchet M, Morgan JC, Akinwuntan AE, Devos H.

Accid Anal Prev. 2020 Jan;134:105328. doi: 10.1016/j.aap.2019.105328. Epub 2019 Oct 19.

Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

Junior NCF, Dos-Santos-Pereira M, Guimarães FS, Del Bel E.

Neurotox Res. 2020 Jan;37(1):12-29. doi: 10.1007/s12640-019-00109-8. Epub 2019 Oct 22. Review.

Impact of prefrontal intermittent theta-burst stimulation on working memory and executive function in Parkinson's disease: A double-blind sham-controlled pilot study.

Hill AT, McModie S, Fung W, Hoy KE, Chung SW, Bertram KL.

Brain Res. 2020 Jan 1;1726:146506. doi: 10.1016/j.brainres.2019.146506. Epub 2019 Oct 18.

Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study.

Pacheco-Paez T, Montastruc F, Rousseau V, Chebane L, Lapeyre-Mestre M, Renoux C, Montastruc JL.

Mov Disord. 2020 Jan;35(1):176-180. doi: 10.1002/mds.27876. Epub 2019 Oct 21.

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study.

Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, Wüllner U, Svenningsson P, Sánchez-Valle R, Molinuevo JL, Corvol J

Alzheimers Dement. 2020 Feb;16(2):292-304. doi: 10.1016/j.jalz.2019.07.018. Epub 2020 Jan 6.

Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.

Fine JM, Stroebel BM, Faltesek KA, Terai K, Haase L, Knutzen KE, Kosyakovsky J, Bowe TJ, Fuller AK, Frey WH, Hanson LR.

Neurosci Lett. 2020 Jan 1;714:134567. doi: 10.1016/j.neulet.2019.134567. Epub 2019 Oct 16.

Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease.

Erga AH, Alves G, Tysnes OB, Pedersen KF.

J Neurol. 2020 Jan;267(1):259-266. doi: 10.1007/s00415-019-09584-7. Epub 2019 Oct 18.

Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.

Mishra A, Singh S, Tiwari V, Bano S, Shukla S.

Behav Brain Res. 2020 Jan 27;378:112304. doi: 10.1016/j.bbr.2019.112304. Epub 2019 Oct 15.

Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.

Martin GP, McDonald KR, Allsop D, Diggle PJ, Leroi I.

J Neurol. 2020 Jan;267(1):214-227. doi: 10.1007/s00415-019-09538-z. Epub 2019 Oct 15.

Delayed Clinical Manifestation of Parkinson's Disease Among Physically Active: Do Participants in a Long-Distance Ski Race Have a Motor Reserve?

Olsson TT, Svensson M, Hållmarker U, James S, Deierborg T.

J Parkinsons Dis. 2020;10(1):267-274. doi: 10.3233/JPD-191762.

The Effects of Computer-Based Cognitive Rehabilitation on Working Memory in Patients with Parkinson's Disease: A Systematic Review.

Svaerke K, Niemeijer M, Løkkegaard A.

J Parkinsons Dis. 2020;10(1):47-57. doi: 10.3233/JPD-191726.

Asymmetry of Periodic Leg Movements in Sleep (PLMS) in Parkinson's Disease.

Hermann W, Flemming T, Brandt MD, Langner S, Reichmann H, Storch A.

J Parkinsons Dis. 2020;10(1):255-266. doi: 10.3233/JPD-191667.

A Dual-Modal Attention-Enhanced Deep Learning Network for Quantification of Parkinson's Disease Characteristics.

Xia Y, Yao Z, Ye Q, Cheng N.

IEEE Trans Neural Syst Rehabil Eng. 2020 Jan;28(1):42-51. doi: 10.1109/TNSRE.2019.2946194. Epub 2019 Oct 8.

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients

Cattaneo C, Jost WH, Bonizzoni E.

J Parkinsons Dis. 2020;10(1):89-97. doi: 10.3233/JPD-191765.

Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.

Di Lazzaro G, Ricci M, Al-Wardat M, Schirinzi T, Scalise S, Giannini F, Mercuri NB, Saggio G, Pisani A.

J Parkinsons Dis. 2020;10(1):113-122. doi: 10.3233/JPD-191758.